BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin S, Lau LH, Chanchlani N, Kennedy NA, Ng SC. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut 2022;71:1426-39. [PMID: 35477864 DOI: 10.1136/gutjnl-2021-326784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Suzuki G, Iwakiri R, Udagawa E, Ma S, Takayama R, Nishiura H, Nakamura K, Burns SP, D’alessandro PM, Fernandez J. Computational Simulation Model to Predict Behavior Changes in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Analysis of Two Regional Japanese Populations. JCM 2023;12:757. [DOI: 10.3390/jcm12030757] [Reference Citation Analysis]
2 Mounsif S, Setouani H, Nadi A, Ghalim F, Delsa H. Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19. Cureus 2022;14:e32153. [PMID: 36601162 DOI: 10.7759/cureus.32153] [Reference Citation Analysis]
3 Clerbaux L, Mayasich SA, Muñoz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim M. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. JCM 2022;11:5691. [DOI: 10.3390/jcm11195691] [Reference Citation Analysis]
4 Kutschera M, Ritschl V, Reichardt B, Stamm T, Kiener H, Maier H, Reinisch W, Benka B, Novacek G. Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. JCM 2022;11:5308. [DOI: 10.3390/jcm11185308] [Reference Citation Analysis]